Prospective, single center, single arm, open label study to evaluate the efficacy and safety of treatment with LinearFirm(ULTRAcel Q+) in temporary eyebrow lifting
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
The avegrage change in AEH (Average Eyebrow Height) and MEH(Maximum Eyebrow Height) compared to the Baseline
Timeframe: Base line and 4, 8, 12, 16weeks
The evaluation of the GLS (Glabellar Line Scale) compared to the Baseline
Timeframe: Base line and 4, 8, 12, 16weeks
The evaluation of the TEAE (Treatment Emergent Adverse Event) and serious AE/ADE
Timeframe: after 16weeks